Form 4: Emergent BioSolutions Executive Sells Shares

William Hartzel, SVP of Bioservices at Emergent BioSolutions Inc., reported a transaction involving the sale of 1,741 shares of common stock.

Summary

• William Hartzel, Senior Vice President of Bioservices at Emergent BioSolutions Inc. (EBS), engaged in a transaction on June 8, 2026.
• The transaction involved the disposal of 1,741 shares of common stock.
• These shares were withheld to cover taxes related to the vesting and settlement of restricted stock units.
• Following this transaction, Hartzel beneficially owns 185,558 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard insider transaction for tax purposes rather than a strategic decision to buy or sell shares based on market outlook.

Negatives

• A sale of company stock by a senior executive can sometimes be perceived negatively by the market, although in this case it was for tax withholding purposes.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. While this specific filing details a tax-related stock withholding, such events are common for executives managing equity compensation and do not inherently signal a change in the company's strategic direction or financial health.

Stakeholder Impact

• Shareholders: The transaction is a routine tax withholding and does not directly impact the number of shares held by the executive beyond covering tax obligations, thus having minimal direct impact on share price or ownership structure.

Key Dates

Keywords

Emergent BioSolutions, EBS, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Restricted Stock Units, Tax Withholding